Paper32456830
Naturally occurring homologous recombination between novel variant infectious bursal disease virus and intermediate vaccine strain.
Wu T and 13 others. Vet Microbiol, 2020. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Naturally occurring homologous recombination between novel variant infectious bursal disease virus and intermediate vaccine strain. Papers, record 32456830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32456830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Naturally occurring homologous recombination between novel variant infectious bursal disease virus and intermediate vaccine strain.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Birnaviridae Infections | Major topic |
| Homologous Recombination | Major topic |
| Infectious bursal disease virus | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Chick Embryo | |
| Chickens | |
| Phylogeny | |
| Poultry Diseases | |
| Specific Pathogen-Free Organisms | |
| Viral Structural Proteins |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42220545 | Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220545 | PubMed |
| 41950753 | Immune protection in chickens via lipid nanoparticle-encapsulated VP2 DNA vaccine against very virulent infectious bursal disease virus. | Poult Sci | 2026 | https://conductscience.org/library/papers/41950753 | PubMed |
| 41472004 | Advances in Infectious Bursal Disease Virus Vaccines-A Review. | Microorganisms | 2025 | https://conductscience.org/library/papers/41472004 | PubMed |
| 38362295 | RNA-seq reveals role of cell-cycle regulating genes in the pathogenicity of a field very virulent infectious bursal disease virus. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/38362295 | PubMed |
| 38146498 | Isolation and genomic characteristics of the novel variant infectious bursal disease virus in China. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/38146498 | PubMed |
| 38075867 | Genetic and pathogenic characterizations of a naturally occurring reassortant and homologous recombinant strain of the classical infectious bursal disease virus re-emerging in chickens in southern China. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38075867 | PubMed |
| 37896821 | Whole Genome Sequencing of Infectious Bursal Disease Viruses Isolated from a Californian Outbreak Unravels the Underlying Virulence Markers and Highlights Positive Selection Incidence. | Viruses | 2023 | https://conductscience.org/library/papers/37896821 | PubMed |
| 37402052 | Phylogenotyping of infectious bursal disease virus in Vietnam according to the newly unified genotypic classification scheme. | Arch Virol | 2023 | https://conductscience.org/library/papers/37402052 | PubMed |
| 37402042 | The attenuated live vaccine strain W2512 provides protection against novel variant infectious bursal disease virus. | Arch Virol | 2023 | https://conductscience.org/library/papers/37402042 | PubMed |
| 37175960 | Genetic Insight into the Interaction of IBDV with Host-A Clue to the Development of Novel IBDV Vaccines. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175960 | PubMed |
| 37008302 | Characterization and pathogenicity of a novel variant infectious bursal disease virus in China. | Front Microbiol | 2022 | https://conductscience.org/library/papers/37008302 | PubMed |
| 36298808 | The Over-40-Years-Epidemic of Infectious Bursal Disease Virus in China. | Viruses | 2022 | https://conductscience.org/library/papers/36298808 | PubMed |
| 33579020 | Development of a Viral-Like Particle Candidate Vaccine Against Novel Variant Infectious Bursal Disease Virus. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33579020 | PubMed |
| 33466596 | The Full Region of N-Terminal in Polymerase of IBDV Plays an Important Role in Viral Replication and Pathogenicity: Either Partial Region or Single Amino Acid V4I Substitution Does Not Completely Lead to the Virus Attenuation to Three-Yellow Chickens. | Viruses | 2021 | https://conductscience.org/library/papers/33466596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32456830
GET https://conductscience.org/api/papers/v1/32456830/authors